Working Wonders is Tufts Medical Center and Floating Hospital for Children's signature fundraising event. Dedicated to raising critical unrestricted support, this annual benefit evening celebrates individuals and organizations who exemplify the values of the Medical Center.  
 

Tuesday, March 24, 2015

     
  6:00 PM - 7:00 PM Cocktail Reception
7:00 PM - 9:00 PM Dinner, Auction & Awards Presentation
Boston Convention & Exhibition Center
415 Summer Street, Boston, MA
Tufts Medical Center Floating Hospital for Children at Tufts Medical Center  
       
    Honorees  
       
  Mark Levin Kevin Starr Robert Tepper
Mark Levin, Kevin Starr & Robert Tepper, MD
Third Rock Ventures
Ellen M. Zane Award for Visionary Leadership
Third Rock Ventures was co-founded by Mark Levin, Kevin Starr and Bob Tepper, M.D., in 2007 with the goal of translating disruptive technologies into valuable business enterprises that can make a difference for patients. Since its inception, Third Rock has raised more than $1.3 billion for investments in healthcare companies, with a particular emphasis on innovative product engines. Third Rock Ventures is a firm dedicated to bankrolling startups at a time when other venture capitalists and big pharmaceutical companies shifted their focus to later-stage drug development.

Third Rock does more than just fund the companies. It helps launch them from scratch and routinely leads its portfolio companies through the early stages of growth. In 2013, three of the firm's companies built with Third Rock's hands on approach went public – gene therapy developer bluebird bio, cancer drug maker Agios Pharmaceuticals, and cancer diagnostics startup Foundation Medicine – and raised a combined $328 million and were among the best-performing biotech IPOs of 2013. The Third Rock portfolio currently includes over 30 companies, mostly Boston-based, including 28 private companies and 6 public companies. Together, these companies have more than 25 drug candidates in clinical trials in areas ranging from gene therapies to cancer metabolism.
 
       
  Paul Kirk
Paul Kirk
Floating Hospital for Children patient
Cam Neely Award for Courage
In the spring of 2012, Paul Kirk, a 17-year-old hopeful high school senior was planning to attend UMass Amherst. Weeks before graduation, Paul was diagnosed with Acute Lymphoblastic Leukemia (ALL) and started chemotherapy. Paul was in and out of the hospital, including a prolonged stay in the Neely Pediatric Bone Marrow Transplant Unit, for the remainder of his senior year causing him to miss his senior prom. Despite many challenges and setbacks throughout his treatment, Paul enrolled as a full-time student at UMass in the fall of 2013 while in the maintenance phase of ALL therapy. Paul chose a biology major and made the monthly two-hour bus commute from Amherst to Boston for his care. This past August, at age 19, Paul was diagnosed with a second cancer, lymphoma, after feeling ill throughout the summer. Still undergoing treatment, Paul will return to UMass this spring to continue his studies in biology. His strength, determination and focus throughout his treatment are a testament to the spirit of the Cam Neely Award for Courage.
 
       
    Event Co-Chairs  
       
   
Robert Beal
Partner and President
Related Beal
 
   
Brian R. Driscoll
Regional Managing Director
Aon Construction Services Group
 
       
    Physician Chair  
       
   
Jonathan M. Davis, MD
Chief, Newborn Medicine
Floating Hospital for Children